Akebia Therapeutics Inc

Most Recent

  • uploads///Graph
    Company & Industry Overviews

    MNKD or AKBA: Which Is Expected to Report Faster Revenue Growth?

    On December 13, 2018, Akebia Therapeutics issued a press release announcing the completion of its merger with Keryx Biopharmaceuticals.

    By Margaret Patrick
  • uploads///dna _
    Company & Industry Overviews

    What Analysts Are Recommending for MannKind and Akebia in March

    On March 12, MannKind Corporation (MNKD) closed at $2.09, 8.29% higher than its previous closing price.

    By Margaret Patrick
  • uploads///Ebay

    Is Seth Klarman Making Money on His New eBay Bet?

    During the fourth quarter, Seth Klarman added 21 million shares of eBay (EBAY) worth $589 million to his portfolio.

    By Anuradha Garg
  • uploads///hands _
    Company & Industry Overviews

    Akebia Therapeutics and Keryx Biopharmaceuticals’ Proposed Merger

    Today, Akebia Therapeutics (AKBA) and Keryx Biopharmaceuticals (KERX) announced an all-stock merger.

    By Margaret Patrick
  • uploads///pills _
    Company & Industry Overviews

    Analysts’ Ratings for Athenex and Its Peers in March

    Of the six analysts covering Athenex in March 2018, five analysts gave the stock a “buy” rating, while one analyst gave it a “hold” rating.

    By Kenneth Smith
  • uploads///dna _
    Company & Industry Overviews

    How Analysts View Agios Pharmaceuticals and Peers in March 2018

    Of the nine analysts covering Agios Pharmaceuticals (AGIO) in March 2018, one gave it a “strong buy” rating, and six gave it a “buy” rating.

    By Kenneth Smith
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.